PortfoliosLab logoPortfoliosLab logo
ACIU vs. RKLB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ACIU vs. RKLB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AC Immune SA (ACIU) and Rocket Lab USA, Inc. (RKLB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ACIU achieves a -30.25% return, which is significantly lower than RKLB's -6.90% return.


ACIU

1D
-7.59%
1M
-12.75%
6M
-31.35%
YTD
-30.25%
1Y
3.30%
3Y*
-9.14%
5Y*
-21.36%
10Y*
ALL TIME*
-17.23%

RKLB

1D
0.42%
1M
-35.35%
6M
-18.88%
YTD
-6.90%
1Y
44.95%
3Y*
107.59%
5Y*
10Y*
ALL TIME*
42.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$404.16K$481.11K$674.22K
$1.17B$1.42B$2.73B

ACIU vs. RKLB - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ACIU
AC Immune SA
-30.25%16.30%-46.00%145.10%-58.79%-26.34%
RKLB
Rocket Lab USA, Inc.
-6.90%173.89%360.58%46.68%-69.30%8.67%

Correlation

The correlation between ACIU and RKLB is 0.27, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.27

Correlation (3Y)
Balances recent behavior with more history.

0.22

Correlation (All Time)
Calculated using the full available price history since Aug 24, 2021

0.22

Fundamentals

Market Cap

ACIU:

$222.88M

RKLB:

$37.60B

EPS

ACIU:

-CHF 0.66

RKLB:

-$0.32

PS Ratio

ACIU:

47.56

RKLB:

54.37

PB Ratio

ACIU:

5.53

RKLB:

17.37

Total Revenue (TTM)

ACIU:

CHF 3.70M

RKLB:

$679.58M

Gross Profit (TTM)

ACIU:

CHF 3.70M

RKLB:

$248.43M

EBITDA (TTM)

ACIU:

-CHF 64.45M

RKLB:

-$177.36M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ACIU vs. RKLB — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ACIU
ACIU Risk / Return Rank: 4646
Overall Rank
ACIU Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
ACIU Sortino Ratio Rank: 4949
Sortino Ratio Rank
ACIU Omega Ratio Rank: 4848
Omega Ratio Rank
ACIU Calmar Ratio Rank: 4545
Calmar Ratio Rank
ACIU Martin Ratio Rank: 4545
Martin Ratio Rank

RKLB
RKLB Risk / Return Rank: 6262
Overall Rank
RKLB Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
RKLB Sortino Ratio Rank: 6666
Sortino Ratio Rank
RKLB Omega Ratio Rank: 6262
Omega Ratio Rank
RKLB Calmar Ratio Rank: 6161
Calmar Ratio Rank
RKLB Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ACIU vs. RKLB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AC Immune SA (ACIU) and Rocket Lab USA, Inc. (RKLB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ACIURKLBDifference
Sharpe ratioReturn per unit of total volatility

-0.42

Sortino ratioReturn per unit of downside risk

-0.67

Omega ratioGain probability vs. loss probability

1.07

1.15

-0.08

Calmar ratioReturn relative to maximum drawdown

0.03

0.68

-0.65

Martin ratioReturn relative to average drawdown

0.05

1.68

-1.63

ACIU vs. RKLB - Sharpe Ratio Comparison

The current ACIU Sharpe Ratio is 0.02, which is lower than the RKLB Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of ACIU and RKLB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ACIU vs. RKLB - Drawdown Comparison

The maximum ACIU drawdown since its inception was -92.33%, which is greater than RKLB's maximum drawdown of -82.96%. Use the drawdown chart below to compare losses from any high point for ACIU and RKLB.


Loading charts...

Drawdown Indicators


ACIURKLBDifference

Max Drawdown

Largest peak-to-trough decline

-92.33%

-82.96%

-9.37%

Max Drawdown (1Y)

Largest decline over 1 year

-46.87%

-60.99%

+14.12%

Max Drawdown (3Y)

Largest decline over 3 years

-70.40%

-60.99%

-9.41%

Max Drawdown (5Y)

Largest decline over 5 years

-81.80%

Current Drawdown

Current decline from peak

-88.65%

-56.77%

-31.88%

Average Drawdown

Average peak-to-trough decline

-69.65%

-51.12%

-18.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.88%

24.74%

+1.14%

Volatility

ACIU vs. RKLB - Volatility Comparison

The current volatility for AC Immune SA (ACIU) is 17.58%, while Rocket Lab USA, Inc. (RKLB) has a volatility of 25.66%. This indicates that ACIU experiences smaller price fluctuations and is considered to be less risky than RKLB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ACIURKLBDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.58%

25.66%

-8.08%

Volatility (6M)

Calculated over the trailing 6-month period

45.27%

73.51%

-28.24%

Volatility (1Y)

Calculated over the trailing 1-year period

77.35%

95.44%

-18.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.41%

82.12%

-3.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

79.34%

82.12%

-2.78%

Dividends

ACIU vs. RKLB - Dividend Comparison

Neither ACIU nor RKLB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ACIU vs. RKLB - Financials Comparison

This section allows you to compare key financial metrics between AC Immune SA and Rocket Lab USA, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ACIU and RKLB have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RKLB has higher volatility (25.66%) compared to ACIU (17.58%). In terms of maximum drawdown, ACIU dropped -92.33% vs RKLB's -82.96%.

RKLB currently has the higher Sharpe Ratio (0.44 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ACIU and RKLB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer